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Background
First developed in France in 1987, Deep Brain Stimulation
(DBS) is a neurosurgical intervention that involves the
implantation of a brain pacemaker, which electrically sti-
mulates specific brain nuclei.1 The FDA approved DBS for
treatment for Essential Tremor in 1997, Parkinson’s
Disease in 2002 and Dystonia in 2003.1 More recently,
DBS has been indicated in management of neuropsychia-
tric disorders such as: Chronic Pain, Major Depression,
Obsessive Compulsive Disorder and Anorexia Nervosa.
Although effective, the exact mode of function of DBS
remains poorly understood. Up to 2012, literature search
yielded 84 peer-reviewed DBS studies that included over
296 psychiatric patients.2 The Canadian United Health
Network (UHN) Krembil Neuroscience Centre is pioneer-
ing DBS research. Current neuroimaging, intra-operative
electrophysiology and emerging DBS electrode and target-
ing technologies have improved DBS accuracy, effective-
ness and acceptability. Objective: To examine the role of
DBS in the management of motor and neuropsychiatric
disorders and to provide, for the first time, a review of all
anatomical DBS targets to date. To evaluate the accuracy
of emerging DBS targeting and electrode technologies.
Methods
Research for this paper was carried out using Pubmed,
UHN online library, Medline, Google Scholar and UHN
Grant Reviews. Papers were limited to those published in
English between the years 2000 and 2013. Research was
conducted at the Department of Radiology at the Toronto
Western Hospital, UHN.
Results
More than 26 anatomical targets have been identified
for the treatment of movement and neuropsychiatric
disorders. There is yet to be a large longitudinal cohort
study confirming DBS usefulness and safety. DBS
decreases disease burden by providing immediate
improvement in the quality of life. Cost-utility analysis
reveals that DBS has a high Quality-Adjusted Life Year
(QALY) score.3 New neuroimaging technologies are
enhancing DBS preoperative neuroimaging planning,
intraoperative neuroimaging guidance and post-opera-
tive neuroimaging follow-up. Anatomical brain atlases,
combined MR/CT, electrophysiological databases, regis-
tered surgical targets of previous patients and integrated
functional and anatomical references have cumulatively
shown to increase DBS targeting accuracy.4 Emerging
research aims at developing electrodes from non-metals
such as Carbon, in order to prevent metal-induced field
distortion and MR artefacts. Guide tubes and stylettes
are being introduced to refine DBS accuracy.
Conclusions
DBS is a promising technology for severe, chronic move-
ment and neuropsychiatric disorders. Continuous efforts to
increase DBS targeting accuracy, improve on current DBS
equipment systems and identify new anatomical targets are
currently internationally pursued.
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